An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN).

NCT00492323 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Postherpetic Neuralgia
Neuralgia
Herpes Zoster

Interventions

DRUG: placebo
DRUG: carisbamate

Sponsor

SK Life Science, Inc.